Innovation Pharmaceuticals Inc.
IPIX · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $10,115 | $15,620 | $83,218 | $97,292 |
| - Cash | $1,518 | $3,807 | $10,194 | $6,018 |
| + Debt | $725 | $1,288 | $1,872 | $2,456 |
| Enterprise Value | $9,322 | $13,101 | $74,896 | $93,730 |
| Revenue | $0 | $18 | $0 | $423 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$373 | $18 | -$378 | $423 |
| % Margin | – | 100% | – | 100% |
| EBITDA | -$2,738 | -$6,544 | -$8,637 | -$6,015 |
| % Margin | – | -36,355.6% | – | -1,422% |
| Net Income | -$3,168 | -$7,041 | -$13,872 | -$6,648 |
| % Margin | – | -39,116.7% | – | -1,571.6% |
| EPS Diluted | -0.006 | -0.014 | -0.036 | -0.03 |
| % Growth | 55% | 61% | -21.7% | – |
| Operating Cash Flow | -$2,106 | -$6,280 | -$9,495 | -$4,156 |
| Capital Expenditures | -$60 | -$80 | -$72 | -$91 |
| Free Cash Flow | -$2,166 | -$6,360 | -$9,567 | -$4,247 |